Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
A supplement to Clinical Neurology News. This supplement was supported by Talecris Biotherapeutics.
• Topics • Faculty/Faculty Disclosures
To view the supplement, click the image above.
Topics
• Diagnosing CIDP
• Therapeutic Options
• The ICE Study
• Best Practices: Key Takeaways
Faculty/Faculty Disclosures
Faculty/Faculty Disclosures Vera Bril, MD Department of Neurology University Health Network Toronto, Ontario, CanadaDr. Bril was a consultant with Talecris Biotherapeutics.
Copyright © 2008 Elsevier Inc.
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
